BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9770805)

  • 1. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
    Nikolov A; Raĭcheva R; Maĭnkhard K
    Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
    Nikolov A; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hysteroresection of submucous myomas after treatment with zoladex].
    Tiufekchieva E; Nikolov A
    Akush Ginekol (Sofiia); 2006; 45(1):19-24. PubMed ID: 16637313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group.
    Gerris J; Degueldre M; Peters AA; Romao F; Stjernquist M; al-Taher H
    Horm Res; 1996; 45(6):279-84. PubMed ID: 8793522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
    Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
    Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goserelin administration causing an acute abdomen in a patient with a fibroid uterus.
    Basu M; Ahmed AI
    J Obstet Gynaecol; 2007 Jan; 27(1):90-1. PubMed ID: 17365475
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of fibromyomas by laparoscopic surgery after preoperative GnRH analogue--an alternative to abdominal hysterectomy or myomectomy.
    Wood C; Maher P
    Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):464-8. PubMed ID: 9006835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of goserelin administration before myomectomy on plasma homocysteine levels in patients with symptomatic uterine leiomyomata.
    Celik H; Ayar A; Kilic N
    Fertil Steril; 2003 Oct; 80(4):1060-1. PubMed ID: 14556836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
    Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
    Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
    McClelland HR; Quinn AJ
    Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist therapy before myomectomy or hysterectomy.
    Gutmann JN; Corson SL
    J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
    Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
    BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical uses of goserelin in gynecologic diseases and its safety].
    Tan SJ; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
    [No Abstract]   [Full Text] [Related]  

  • 16. [New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
    Gesenhues T; Hackenberg R; Diechert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():96-8. PubMed ID: 2522904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography.
    Lee WL; Liu RS; Yuan CC; Chao HT; Wang PH
    Fertil Steril; 2001 Mar; 75(3):638-9. PubMed ID: 11239559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pregnancy in nullipara after conservative excision of uterine cellular leiomyoma and supplementary GnRH analog therapy].
    Cyrkowicz A; Fiala J; Wilkoszewski R
    Ginekol Pol; 1998 Feb; 69(2):91-3. PubMed ID: 9591388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonists: an alternative to surgery?
    Maheux R
    Hum Reprod; 1996 Nov; 11 Suppl 3():43-50. PubMed ID: 9147101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.